Assenagon Asset Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-211,647
| Closed | -$216K | – | 1319 |
|
|
2024
Q2 | $216K | Sell |
211,647
-578,836
| -73% | -$590K | ﹤0.01% | 1320 |
|
|
2024
Q1 | $1.45M | Buy |
+790,483
| New | +$1.45M | ﹤0.01% | 948 |
|
|
2023
Q2 | – | Sell |
-12,450
| Closed | -$6.98K | – | 1277 |
|
|
2023
Q1 | $6.98K | Buy |
+12,450
| New | +$6.98K | ﹤0.01% | 1355 |
|
|
2022
Q2 | – | Sell |
-104,092
| Closed | -$75K | – | 1396 |
|
|
2022
Q1 | $75K | Buy |
+104,092
| New | +$75K | ﹤0.01% | 1335 |
|
|
2020
Q1 | – | Sell |
-12,146
| Closed | -$77K | – | 729 |
|
|
2019
Q4 | $77K | Buy |
+12,146
| New | +$77K | ﹤0.01% | 698 |
|